Navid Sobhani

Scientist, Ph.D.


Curriculum vitae


[email protected]


Department of Cancer Biology

UT MD Anderson Cancer Center



Advances in anti-BRAF therapies for lung cancer


Journal article


Giandomenico Roviello, Alberto D'Angelo, Marianna Sirico, Matteo Pittacolo, Felipe Umpierre Conter, Navid Sobhani
vol. 39(3), 2021, pp. 879-890


Cite

Cite

APA   Click to copy
Roviello, G., D'Angelo, A., Sirico, M., Pittacolo, M., Conter, F. U., & Sobhani, N. (2021). Advances in anti-BRAF therapies for lung cancer, 39(3), 879–890. https://doi.org/10.1007/s10637-021-01068-8


Chicago/Turabian   Click to copy
Roviello, Giandomenico, Alberto D'Angelo, Marianna Sirico, Matteo Pittacolo, Felipe Umpierre Conter, and Navid Sobhani. “Advances in Anti-BRAF Therapies for Lung Cancer” 39, no. 3 (2021): 879–890.


MLA   Click to copy
Roviello, Giandomenico, et al. Advances in Anti-BRAF Therapies for Lung Cancer. Vol. 39, no. 3, 2021, pp. 879–90, doi:10.1007/s10637-021-01068-8.


BibTeX   Click to copy

@article{giandomenico2021a,
  title = {Advances in anti-BRAF therapies for lung cancer},
  year = {2021},
  issue = {3},
  pages = {879-890},
  volume = {39},
  doi = {10.1007/s10637-021-01068-8},
  author = {Roviello, Giandomenico and D'Angelo, Alberto and Sirico, Marianna and Pittacolo, Matteo and Conter, Felipe Umpierre and Sobhani, Navid}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in